JG
SRPT icon

Jain Global’s Sarepta Therapeutics SRPT Stock Holding History

Jain Global’s Portfolio SRPT Stock Details SRPT Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q1 		$1.9M Buy
+87,428
New +$1.69M 0.01% 695
2025
Q3 		– Sell
-282,437
Closed -$4.83M – 1465
2025
Q2 		$4.83M Buy
+282,437
New +$12M 0.04% 348
2025
Q1 		– Sell
-18,193
Closed -$2.21M – 1327
2024
Q4 		$2.21M Buy
+18,193
New +$2.23M 0.07% 223

Other funds holding SRPT

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
VPM
Vanguard Portfolio Management Malvern, Pennsylvania $1.91T AUM
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
AQR Capital Management
AQR Capital Management Greenwich, Connecticut $218B AUM 29.41% 1-Year Est. Return
Two Sigma Investments
Two Sigma Investments New York $124B AUM 33.93% 1-Year Est. Return
VCM
Vanguard Capital Management Malvern, Pennsylvania $4.04T AUM
First Trust Advisors
First Trust Advisors Wheaton, Illinois $140B AUM 27.84% 1-Year Est. Return
RCM
RA Capital Management Boston, Massachusetts $9.44B AUM 157.3% 1-Year Est. Return
EAM
Erste Asset Management Vienna, Austria $10.8B AUM 38.54% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return

Jain Global's SRPT Position: Q1 2026 in Review

Jain Global opened a new position in Sarepta Therapeutics (SRPT) in Q1 2026: 87,428 shares worth $1.9M. The stake represents 0.01% of the portfolio and ranks #695 among its holdings. This is a return to the name: Jain Global previously reported a position in SRPT as recently as Q2 2025.

Jain Global first reported a position in SRPT in Q4 2024 and has held it in 3 quarters since. The position peaked at $4.83M in Q2 2025. 339 funds tracked by Wall St. Rank hold SRPT as of Q1 2026.

  • Jain Global held 87,428 shares of Sarepta Therapeutics worth $1.9M as of Q1 2026.
  • Sarepta Therapeutics was a new Jain Global position in Q1 2026.
  • Sarepta Therapeutics made up 0.01% of Jain Global's portfolio in Q1 2026, its #695 holding.
  • Jain Global first reported a position in Sarepta Therapeutics in Q4 2024 and has held it in 3 quarters since.
  • Jain Global's Sarepta Therapeutics position peaked at $4.83M in Q2 2025.
  • 339 funds tracked by Wall St. Rank held Sarepta Therapeutics as of Q1 2026.

Based on Jain Global's 13F filing for Q1 2026, filed 15 May 2026.